Use this url to cite publication: https://hdl.handle.net/20.500.12512/92262
Subcutaneous merkel cell carcinoma in a psoriatic patient treated with methotrexate and TNF-α inhibitors
Type of publication
Straipsnis Scopus duomenų bazėje / Article in Scopus database (S1b)
Author(s)
| Author | Affiliation |
|---|---|
Silling, S | National Reference Center for Papilloma and Polyoma Viruses, Institute of Virology, University of Cologne, Germany |
Title
Subcutaneous merkel cell carcinoma in a psoriatic patient treated with methotrexate and TNF-α inhibitors
V. Kucinskiene, V. Vilkickaite, J. Makstiene, S. Silling, S. Valiukeviciene
Other Title
Subkutanes Merkelzellkarzinom bei einem Psoriasis-Patienten unter der Behandlung mit Methotrexat und TNF-α-Inhibitoren
Extent
p. 404-407
Is part of
Aktuelle Dermatologie. Stuttgart : Thieme, 2014, Jg. 40, H. 10.
Version
Originalus / Original
Series/Report no.
Eine Klinik im Blickpunkt
Abstract (en)
TNF-α inhibitors are used for the treatment of chronic inflammatory diseases and provide a high degree of clinical efficacy in patients with severe psoriasis. Although the effect of blocking agents gives significant improvements in quality of life of psoriatic patients, the use of them might lead to neoplasia not observed before the treatment. We present a case of Merkel cell carcinoma in a patient with a long-standing history of psoriasis and psoriatic arthritis treated with methotrexate and TNF-α inhibitors (etanercept and infliximab).
Type of document
type::text::journal::journal article
ISSN (of the container)
0340-2541
Other Identifier(s)
(LSMU ALMA)990000853250107106
Coverage Spatial
Vokietija / Germany (DE)
Language
Anglų / English (en)
Bibliographic Details
23
Date Reporting
2014